Novo Integrated Sciences Inc. (NASDAQ: NVOS) stock fell -6.10% on Friday to $0.40 against a previous-day closing price of $0.43. With 29.37 million shares changed hands, the volume of the stock remained lighter than its average volume of 42.93 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $0.4100 whereas the lowest price it dropped to was $0.3310. The 52-week range on NVOS shows that it touched its highest point at $1.29 and its lowest point at $0.07 during that stretch. Beta for the stock currently stands at -0.34.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NVOS was up-trending over the past week, with a rise of 49.53%, but this was up by 120.87% over a month. Three-month performance surged to 197.40% while six-month performance rose 246.32%. The stock lost -61.11% in the past year, while it has gained 98.91% so far this year.
Float and Shares Shorts:
At present, 157.59 million NVOS shares are outstanding with a float of 144.38 million shares on hand for trading. On Aug 30, 2023, short shares totaled 4.96 million, which was 3.15% higher than short shares on Jul 30, 2023. In addition to Mr. Robert Mattacchione as the firm’s Chairman & CEO, Mr. Christopher Mehlin David serves as its COO, Pres & Director.
Institutional Ownership:
Through their ownership of 0.47% of NVOS’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 1.55% of NVOS, in contrast to 0.15% held by mutual funds. Shares owned by individuals account for -0.07%. As the largest shareholder in NVOS with 0.55% of the stake, Geode Capital Management LLC holds 816,601 shares worth 816,601. A second-largest stockholder of NVOS, SSgA Funds Management, Inc., holds 290,192 shares, controlling over 0.20% of the firm’s shares. The Vanguard Group, Inc. is the third largest shareholder in NVOS, holding 238,861 shares or 0.16% stake. With a 0.85% stake in NVOS, the Vanguard Extended Market Index Fu is the largest stakeholder. A total of 1,261,880 shares are owned by the mutual fund manager. The Fidelity Extended Market Index Fu, which owns about 0.48% of NVOS stock, is the second-largest Mutual Fund holder. It holds 708,628 shares valued at 99208.0. Fidelity Series Total Market Inde holds 0.16% of the stake in NVOS, owning 230,526 shares worth 32274.0.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NVOS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded NVOS stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.
